Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7233 USD | -7.27% |
|
-2.69% | +6.40% |
06-11 | AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc | CI |
05-13 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
88.48M | - | - | - | - | - | |
122B | ||||||
113B | ||||||
26.49B | - | |||||
19.4B | - | |||||
16.24B |
- Stock Market
- Equities
- ALVR Stock
- Charts AlloVir, Inc.
- Sector Chart